🔍 3 key benefits in addressing 𝐬𝐭𝐞𝐫𝐧𝐚𝐥 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐜𝐨𝐦𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬? 💡 🔹 𝐈𝐝𝐞𝐧𝐭𝐢𝐟𝐲 𝐑𝐞𝐝 𝐅𝐥𝐚𝐠𝐬 𝐄𝐚𝐫𝐥𝐲: The MUST score allows you to categorise patients by risk, ensuring those at higher risk receive the attention they need. 🔹 𝐓𝐚𝐢𝐥𝐨𝐫𝐞𝐝 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬: With adaptable treatment options for all risk levels, you can proactively choose the best approach for each patient. This helps to achieve better results, even in the most complex cases. 🔹 𝐁𝐚𝐥𝐚𝐧𝐜𝐞𝐝 𝐂𝐚𝐫𝐞: Implement strategies that improve patient outcomes while keeping costs in check. This balance helps maintain high standards of care without financial strain. 🎥 Watch our expert-led webinair and explore these benefits, available below 👇 #CardiacSurgery #PatientCare #SurgicalInnovation #ERAS #SternalClosure 𝘍𝘰𝘳 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯 𝘰𝘯 𝘱𝘳𝘰𝘥𝘶𝘤𝘵 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘪𝘭𝘪𝘵𝘺, 𝘱𝘭𝘦𝘢𝘴𝘦 𝘳𝘦𝘢𝘤𝘩 𝘰𝘶𝘵 𝘵𝘰 𝘺𝘰𝘶𝘳 𝘭𝘰𝘤𝘢𝘭 𝘴𝘢𝘭𝘦𝘴 𝘳𝘦𝘱𝘳𝘦𝘴𝘦𝘯𝘵𝘢𝘵𝘪𝘷𝘦.
Zimmer Biomet EMEA’s Post
More Relevant Posts
-
US HCPs: Dr. Jeff Beecher showcases a standout Science Based Aspiration Thrombectomy (SBAT) case utilizing BMX81, Velocity, and RED 62 in the M1. The case highlights the power of optimal catheter sizing for effective recanalization. "And some people say we need catheters larger than a 72." Excellent work, Dr. Beecher! Rx only. For risk info: peninc.info/risk Clinical results may vary
-
Wanna hear what's true? Inceptiv™ with closed-loop sensing technology ensures consistent therapy dose. It senses† 100% of the time and makes a decision to hold or adjust therapy every 20ms in real time. Ready to explore the future of pain treatment? Find out how! See risk information: https://bit.ly/3CSw2Kn Go to Medtronic.com/Inceptiv to learn more about ECAPS and closed-loop technology with Inceptiv™ SCS. Connect with your Metronic Representative today! #MDTPainInterventional #PatientFirst #InceptivSCS #ClosedLoopTechnology #MedtronicSCS #ClosedLoop #SCS #SpinalCordStimulation #ECAP #MRIAccess †Sensing signals may not be measurable in all cases Product usage represented may not be approved or cleared in all markets.
-
"Unveiling the Unseen by Unlocking Unparalleled Clarity" 🚀 Exciting News! 🚀 We are thrilled to announce the launch of our new Automated Urine Analysis System Mindray EU 5300 Pro! This state-of-the-art technology is designed to provide quick, accurate, and reliable results, revolutionizing the way urine analysis is performed. Say goodbye to lengthy lab wait times and hello to streamlined diagnostics. Perfect for diagnostics, clinics, hospitals, and research facilities! Stay ahead with innovation. Discover more about our new system today! #MedicalInnovation #HealthcareTech #UrineAnalysis
-
-
🫀“The quality of the signal becomes of paramount importance.” 🫀 #EPExpertise: Dr. Miguel Valderrabano, MD, PhD shares his perspective on why the ability to see good, quality signals is relevant as EPs focus on understanding the mechanisms of atrial fibrillation in each individual patient. #medtech #epeeps #clinicalexperience
-
Simply the best and smallest/thinnest SCS battery on the market. Inceptiv automatically senses and responds every 20 ms to the patients ECAP’s. That is five times faster than the blink of an eye. 1.5 & 3T compatiable! Patients no longer have to worry about being over/under dosed and receiving suboptimal therapy. In addition, Inceptiv can deliver multiple different HD wave forms that our competion can’t! What is not to like? #mdtemployee #gamechanger #overdrivetechnology
Why Inceptiv™ closed-loop sensing technology? How does it work? How does it help SCS patients? Learn from pain management physicians Drs. Melissa Murphy, MD, MPH and Krishnan Chakravarthy M.D., Ph.D, along with Distinguished Biomedical Engineer at Medtronic, Dave Dinsmoor, P.E., why Inceptiv™ closed-loop SCS system is set to transform SCS therapy. The Inceptiv™ system senses† and responds automatically adjusting stimulation based on their neural responses to maintain consistant therapy during all patient activites. See risk information: https://bit.ly/4bca1CB Sense the future with Inceptiv™ SCS! Go to https://lnkd.in/ezEmPGNc or talk to your Medtronic Representative to learn more about why Inceptiv™ SCS system is the most advanced SCS system with closed-loop technology. †Sensing signals may not be measurable in all cases. #MDTPainInterventions #PatientFirst #InceptivSCS #ClosedLoopTechnology #MedtronicSCS #ClosedLoop #SCS #SpinalCordStimulation #ECAP
-
🗺️ Navigate regulatory challenges with Fivos. Explore some of our past #vascular and #neurovascular projects to see how you too can unlock new device potential — https://lnkd.in/gUY_Pc-4. #EUMDR #LabelExpansion #ExternalControlArms #PropensityScoreMatching #CoreLabIntegration #RWE
-
-
We are excited to announce that Wilex are now venturing into filters for the healthcare sector. Hengst Filtration builds filters for specialised medical applications, ranging from routine pulmonary function tests, all the way to electrosurgery.
-
-
#SCOPESummit welcomes Christine Fernandez https://lnkd.in/eY7EdvwA sharing insights on comprehensive CGT vein-to-vein tracking processes including: 🔹 Proper storage conditions and specialized containers used to preserve cell products 🔹 Real-time tracking during transit ensures timely and safe delivery to clinical sites 🔹 Product identity and patient match are verified to ensure accuracy 🔹 Advanced tracking technologies that enhance accuracy 🔹 Data integration facilitating seamless information flow each underscore the critical role of precision and reliability in the successful delivery of CGT products.
-
-
Senior Writer and Editor at Premier MedTech Publication; Content Creator, Storyteller, Insightful Interviewer
Venstra Medical is overcoming the challenges of the current generation of PVADs providing cardiac support for cardiogenic shock, the number one cause of cardiac death in the hospital. Unlike current devices, Venstra doesn’t make tradeoffs between size/ease of delivery or adequate flow.
Now presenting at #InnovationSanDiego is Venstra Medical with CEO Martin Cook. Venstra Medical (Newcastle, Australia and Minneapolis, MN, USA) has developed the smallest and most powerful next-generation temporary cardiac assist device, a percutaneous catheter-based pump (pVAD) protected by 7 issued patents, that allows for the device to be collapsed into a low-profile 9Fr catheter for insertion. Their novel pVAD technology is the most powerful and smallest pVAD technology that they know, able to provide over 7L/min at physiological pressures and provide total left ventricular support for cardiogenic shock and other critically ill patients. Remain informed on new articles, conference updates and more with our helpful #medtech community newsletter. Subscribe here: https://bit.ly/42KHJKI
-
